FDA authorizes emergency use of influenza medications, diagnostic tests in response to swine flu outbreak

April 28 2009

The FDA, in response to requests from the CDC, has issued Emergency Use Authorizations (EUAs) to make diagnostic and therapeutic tools, including the rRT-PCR Swine Flu Panel and Tamiflu (oseltamivir, from Roche) and Relenza (zanamivir, from GlaxoSmithKline) antiviral products, available to public health and medical workers to identify and respond to the swine flu virus under certain circumstances.

<< Return to FDA authorizes emergency use of influenza medications, diagnostic tests in response to swine flu outbreak

Your Email Address:

Recipient(s) Email Address:

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Include a message (optional):

The e-mail address(es) that you supply to use this service will only be used to send the requested article.